- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02000037
Interest in the Medium Term of an Infrared Reflexotherapy on Overweight or Class I Obese People (REFLEX-IR)
December 6, 2022 updated by: Jean-Michel Lecerf, Institut Pasteur de Lille
The study aim is to Assess the Effect of an IR Reflexotherapy on Overweight and Class I Obese People.
Study Overview
Status
Terminated
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
87
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nord
-
Lille, Nord, France, 59019
- NutrInvest - Institut Pasteur de Lille
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMI between 27 and 35 kg/m2 (included),
- Aged 30 to 60 years old (included),
- Stable weight: no variation of 3 kg in the las 3 months,
- Signed the consent form,
- Able to follow the study,
- Health insured.
Exclusion Criteria:
- History of coronary disease (in the last 6 months),
- Progressive illness at the time of the study (cancer, neurodegenerative disease...),
- Diabetics (treated or not),
- Fasting blood total cholesterol equal or over 2.5 g/L (treated or not),
- Fasting blood triglycerides equal or over 2.0 g/L (treated or not),
- Fasting blood glucose equal or over 1.26 g/L,
- Peripheral neuropathy (polyneuritis, diabetic neuropathy) or central neuropathy (hemiplegia),
- Infectious cutaneous condition or allergies (to the contact point of the device),
- History of stroke,
- Severe heart disease,
- Epilepsy,
- Reduced motility,
- Diagnosed eating disorder,
- Followed a diet in the last 90 days in order to lose weight,
- Took weight loss assistance drug (Orlistat) in the last month or is likely to take one during the study,
- Psychiatric disorder incompatible with the study,
- Mental illness,
- Neurological disorder,
- Chronic somatic disease,
- Addiction or nicotine withdrawal,
- Under psychoactive drug ,
- Alcool consumption over 3 glasses a day,
- Pregnant or breastfeeding women,
- Women that are likely to get pregnant during the study,
- Is unable to understand or follow the protocol
- Is deprived of liberty
- Is under judicial protection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Dietary care
Treatment is composed of a dietary care (with advices on physical activity) given by a professional (dietician of the Nutrition Department of the Institut Pasteur de Lille).
|
Dietary consultation 1, 2, 3, 6, 9, 12, 15 and 18 months after the beginning of the study
|
Experimental: IR reflexotherapy + dietary care
Treatment is composed of :
|
Dietary consultation 1, 2, 3, 6, 9, 12, 15 and 18 months after the beginning of the study
18 IR reflexotherapy sessions :
|
Experimental: IR Reflexotherapy
Treatment is composed of IR reflexotherapy sessions given by a trained professional.
|
18 IR reflexotherapy sessions :
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Weight changes after 12 months compared to a dietary care (associated with physical activity advice) dispensed by a professional.
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Effect of infrared (IR) reflexotherapy on weight changes.
Time Frame: 3, 12 and 18 months
|
3, 12 and 18 months
|
Effect of IR reflexotherapy combined with a dietary care (and physical activity advises) dispensed by a professional on the weight changes.
Time Frame: 3, 12 and 18 months.
|
3, 12 and 18 months.
|
Effect of infrared (IR) reflexotherapy on waist size.
Time Frame: 3, 12 and 18 months
|
3, 12 and 18 months
|
Effect of IR reflexotherapy combined with a dietary care (and physical activity advises) dispensed by a professional on the waist siez.
Time Frame: 3, 12 and 18 months.
|
3, 12 and 18 months.
|
Effect of infrared (IR) reflexotherapy on dietary habits.
Time Frame: 3, 12 and 18 months
|
3, 12 and 18 months
|
Effect of IR reflexotherapy combined with a dietary care (and physical activity advises) dispensed by a professional on dietary habits.
Time Frame: 3, 12 and 18 months.
|
3, 12 and 18 months.
|
Effect of infrared (IR) reflexotherapy on life's quality (anxiety, depression, physical impact, psychosocial, impact on sexual life, eating well-being, feeling about the dietary care).
Time Frame: 3, 12 and 18 months
|
3, 12 and 18 months
|
Effect of IR reflexotherapy combined with dietary care (and physical activity advises) dispensed by professional on life quality (anxiety, depression, physical impact, psychosocial, impact on sexual life, eating wellbeing, feeling about the dietary care)
Time Frame: 3, 12 and 18 months.
|
3, 12 and 18 months.
|
Effect of infrared (IR) reflexotherapy on the salivary cortisol.
Time Frame: 3 months
|
3 months
|
Effect of IR reflexotherapy combined with a dietary care (and physical activity advises) dispensed by a professional on the salivary cortisol.
Time Frame: 3 months.
|
3 months.
|
Effect of infrared (IR) reflexotherapy on blood pressure and heart rate.
Time Frame: 3 months
|
3 months
|
Effect of IR reflexotherapy combined with a dietary care (and physical activity advises) dispensed by a professional on blood pressure and heart rate.
Time Frame: 3 months.
|
3 months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jean-Michel LECERF, MD, Institut Pasteur de Lille
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 18, 2013
Primary Completion (Actual)
January 28, 2016
Study Completion (Actual)
January 28, 2016
Study Registration Dates
First Submitted
November 26, 2013
First Submitted That Met QC Criteria
November 26, 2013
First Posted (Estimate)
December 3, 2013
Study Record Updates
Last Update Posted (Estimate)
December 8, 2022
Last Update Submitted That Met QC Criteria
December 6, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013-A00800-45
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dietary care
-
National Taiwan University HospitalCompleted
-
M.D. Anderson Cancer CenterActive, not recruiting
-
Yale UniversityNational Cancer Institute (NCI)Active, not recruiting
-
University of CopenhagenZealand University HospitalEnrolling by invitationHematological MalignancyDenmark
-
Capital Medical UniversityRecruitingGestational Diabetes Mellitus | Hypertensive Disorder of PregnancyChina
-
Providence Health & ServicesCompletedHypertensionUnited States
-
Shijiazhuang People's HospitalCompletedQuality of Life | Multidisciplinary Collaborative | Palliative Care ModelChina
-
Steno Diabetes Center CopenhagenUniversity of CopenhagenCompletedGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Type2 DiabetesDenmark
-
Jens Rikardt AndersenDepartment of Oncology, Rigshospitalet, Blegdamsvej 9, 2100 CopenhagenUnknownWeight Loss | Abdominal Cancer | Radiotherapy; Complications | Protein Deficiency | Energy SupplyDenmark
-
Hospital Beatriz ÂngeloCompletedGastrointestinal Cancer | AdherencePortugal